Comparison
Ivim Health vs Mochi Health
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Ivim Health | Mochi Health | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $548/mo (monthly plan) | from $278/mo (monthly plan) |
| Semaglutide price | from $299/mo (monthly plan) | from $165/mo (3-mo prepay) |
| Pharmacy receipt | Fills through Empower, Tailor Made per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest. | Fills through DCA Pharmacy, Empower +2 per market data — Empower is an FDA-registered 503B outsourcing facility (federal cGMP oversight). Pick your state to check the rest. |
| Care receipt | In-house clinicians; check-ins and coaching on record. | Outsourced contract clinicians — the brand doesn't employ your clinician — with check-ins and coaching on record. |
| Review integrity | Review-integrity flag — 66% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. | Clean review record — 5% unprompted on 4,934 reviews, within our 40% threshold. |
| Company address | Lists a real-looking operating address on its own site. | Lists a real-looking operating address on its own site. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | In review | 50 states |
| Pharmacy model | Telehealth platform that does not compound medication itself; a licensed provider evaluates the patient and prescribes compounded semaglutide or tirzepatide, which is then filled by external state-licensed compounding pharmacies. Ivim describes these as FDA-regulated, state-licensed compounding pharmacies and references Certificate of Analysis, sterility, potency, pH, and endotoxicity testing, but does not publicly name them. The FDA warning letter (02/20/2026) found that Ivim is not the compounder of the products despite product labels bearing the Ivim name. | Marketplace model: Mochi routes prescriptions to a network of compounding pharmacies and says patients pick a partner pharmacy in the patient portal. Mochi does not publish a full list of its partner pharmacies. One reported affiliated pharmacy, Aequita Pharmacy of Kirkland, WA, was subject to a Washington State Limited Stop Service in March 2025 and reportedly closed in April 2025. |
| Red flags on file | 1 | 3 |
Full profiles: Ivim Health → · Mochi Health →
State-aware license reads: the tirzepatide price board →